Click Here for 5% Off Your First Aladdin Purchase!

Daclizumab (anti-IL2RA) - Primary antibody, specific to IL2RA, >95%, high purity, Human IgG1, INHIBITOR of Interleukin-2 receptor inhibitor

  • Azide Free
  • Carrier Free
  • ExactAb™
  • Low Endotoxin
  • Recombinant
  • Validated
  • ≥95%(SDS-PAGE&SEC)
  • Lot by Lot
Features and benefits
  • Short Overview:

    Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

  • Species reactivity(Reacts with): Human,Mouse,Rat,Rhesus monkey
  • Isotype: Human IgG1
    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
Item Number
Ab170892
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab170892-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$59.90
Ab170892-1mg
1mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$297.90
Ab170892-5mg
5mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$777.90
Ab170892-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$12,288.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product NameDaclizumab (anti-IL2RA) - Primary antibody, specific to IL2RA, >95%, high purity, Human IgG1
SynonymsInterleukin 2 receptor alpha chain antibody; CD25 antibody; CD25 antigen antibody; IDDM10 antibody; IL 2 receptor alpha subunit antibody; IL-2 receptor subunit alpha antibody; IL-2-RA antibody; IL-2R subunit alpha antibody; IL2 RA antibody; IL2 Receptor a
Specifications & PurityExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
SpecificityIL2RA
ConjugationUnconjugated
GradeAzide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action TypeINHIBITOR
Mechanism of actionINHIBITOR of Interleukin-2 receptor inhibitor
Product Description

Daclizumab (anti-IL2RA) is a humanized, monoclonal antibody that blocks CD25 (α-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA)). Daclizumab (anti-IL2RA) reversibly binds to CD25and prevents the interaction of IL-2 with the IL-2R-HA. Daclizumab (anti-IL2RA) can be used for multiple sclerosis research.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Product Properties

IsotypeHuman IgG1
Light Chain Typekappa
SDS-PAGE27.1 kDa (Light Chain) & 51.4 kDa (Heavy Chain), under reducing conditions; 178.6 kDa, under non-reducing conditions.
Purification MethodProtein A purified
Purity>95%
FormLiquid
ConcentrationLot by Lot
Storage TempStore at -80°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS152923-56-3

Images

Daclizumab (anti-IL2RA) (Ab170892) - Flow Cytometry
Flow Cytometry analysis of PHA-stimulated (3 days) human peripheral blood mononuclear lymphocytes labelling IL2RA (red) with Daclizumab (anti-IL2RA) (Ab170892). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

Daclizumab (anti-IL2RA) (Ab170892) - SEC
The purity of Daclizumab (anti-IL2RA) (Ab170892) is more than 95% verified by HPLC.

Daclizumab (anti-IL2RA) (Ab170892) - ELISA
Immobilized TARGET at 2 μg/mL can bind Daclizumab (anti-IL2RA) (Ab170892) with the EC₅₀ of 31.47 ng/mL.

Associated Targets

IL2RA Tclin Interleukin-2 receptor subunit alpha 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

2 results found

Lot NumberCertificate TypeDateItem
ZJ23F1001292Certificate of AnalysisOct 13, 2023 Ab170892
ZJ23F1001293Certificate of AnalysisOct 13, 2023 Ab170892

Related Documents

References

1. Kiyokawa, T T and 8 more authors..  (1989)  Cytotoxicity of interleukin 2-toxin toward lymphocytes from patients with adult T-cell leukemia..  Cancer research,    (15):   [PMID:2786749]
2. Leonard, W J WJ and 7 more authors..  (1985)  Structure of the human interleukin-2 receptor gene..  Science (New York, N.Y.),    (8):   [PMID:2996141]
3. Ishida, N N and 7 more authors..  (1985)  Molecular cloning and structure of the human interleukin 2 receptor gene..  Nucleic acids research,    (11):   [PMID:2999698]
4. Cross, S L SL and 5 more authors..  (1987)  Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I..  Cell,    (10):   [PMID:3030566]
5. Miedel, M C MC, Hulmes, J D JD, Weber, D V DV, Bailon, P P and Pan, Y C YC..  (1988)  Structural analysis of recombinant soluble human interleukin-2 receptor. Primary structure, assignment of disulfide bonds and core IL-2 binding structure..  Biochemical and biophysical research communications,    (15):   [PMID:3134887]
6. Leonard, W J WJ and 9 more authors..  (1984)  Molecular cloning and expression of cDNAs for the human interleukin-2 receptor..  Nature,      [PMID:6090948]
7. Nikaido, T T and 8 more authors..  (1984)  Molecular cloning of cDNA encoding human interleukin-2 receptor..  Nature,      [PMID:6090949]
8. Bamborough, P P, Hedgecock, C J CJ and Richards, W G WG..  (1994)  The interleukin-2 and interleukin-4 receptors studied by molecular modelling..  Structure (London, England : 1993),    (15):   [PMID:7529123]
9. Krouwels, F H FH and 5 more authors..  (1996)  Glucocorticosteroids affect functions of airway- and blood-derived human T-cell clones, favoring the Th1 profile through two mechanisms..  American journal of respiratory cell and molecular biology,      [PMID:8600944]
10. Berard, J L JL, Velez, R L RL, Freeman, R B RB and Tsunoda, S M SM..  (1999)  A review of interleukin-2 receptor antagonists in solid organ transplantation..  Pharmacotherapy,      [PMID:10512062]
11. Deloukas, P P and 135 more authors..  (2004)  The DNA sequence and comparative analysis of human chromosome 10..  Nature,    (27):   [PMID:15164054]
12. Wang, Xinquan X, Rickert, Mathias M and Garcia, K Christopher KC..  (2005)  Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors..  Science (New York, N.Y.),    (18):   [PMID:16293754]
13. Garcia, C D CD and 5 more authors..  ()  Plasmapheresis for recurrent posttransplant focal segmental glomerulosclerosis..  Transplantation proceedings,      [PMID:16908318]
14. and Turturro, Francesco F..  (2007)  Denileukin diftitox: a biotherapeutic paradigm shift in the treatment of lymphoid-derived disorders..  Expert review of anticancer therapy,      [PMID:17187516]
15. and Waldmann, Thomas A..  (2007)  Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey..  Journal of clinical immunology,      [PMID:17216565]
16. and Waldmann, T A TA..  (2007)  Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphoma..  Oncogene,    (28):   [PMID:17530023]
17. Lowe, Christopher E CE and 12 more authors..  (2007)  Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes..  Nature genetics,      [PMID:17676041]
18. Duvic, Madeleine M and Talpur, Rakhshandra R..  (2008)  Optimizing denileukin diftitox (Ontak) therapy..  Future oncology (London, England),      [PMID:18684057]
19. Goudy, Kevin K and 18 more authors..  (2013)  Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity..  Clinical immunology (Orlando, Fla.),      [PMID:23416241]
20. Bezrodnik, L L, Caldirola, M S MS, Seminario, A G AG, Moreira, I I and Gaillard, M I MI..  (2014)  Follicular bronchiolitis as phenotype associated with CD25 deficiency..  Clinical and experimental immunology,      [PMID:24116927]
21. Chen, X X, Ji, Z L ZL and Chen, Y Z YZ..  (2002)  TTD: Therapeutic Target Database..  Nucleic acids research,    (1):   [PMID:11752352]

Solution Calculators